Lundbeck
HLUN-B.CO
#2596
Rank
โ‚น595.22 B
Marketcap
โ‚น627.16
Share price
0.63%
Change (1 day)
21.41%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): โ‚น73.95 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น3.61 Billion. In 2024 the company made an earning of โ‚น49.74 Billion, an increase over its 2023 earnings that were of โ‚น39.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น73.95 B48.65%
2024 โ‚น49.74 B25.74%
2023 โ‚น39.56 B21.77%
2022 โ‚น32.49 B31.57%
2021 โ‚น24.69 B-4.61%
2020 โ‚น25.88 B-45.06%
2019 โ‚น47.12 B-34.04%
2018 โ‚น71.44 B12.83%
2017 โ‚น63.32 B93.99%
2016 โ‚น32.64 B-137.28%
2015 -โ‚น87.56 Billion-1246.24%
2014 โ‚น7.63 B-72.36%
2013 โ‚น27.63 B4.38%
2012 โ‚น26.47 B-55.18%
2011 โ‚น59.07 B5.65%
2010 โ‚น55.91 B-5.9%
2009 โ‚น59.42 B